175 related articles for article (PubMed ID: 30641095)
1. Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis.
Schmidt T; Schwinge D; Rolvien T; Jeschke A; Schmidt C; Neven M; Butscheidt S; Kriz M; Kunzmann L; Mussawy H; Hubert J; Hawellek T; Rüther W; Oheim R; Barvencik F; Lohse AW; Schramm C; Schinke T; Amling M
J Hepatol; 2019 May; 70(5):941-953. PubMed ID: 30641095
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
4. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis.
Katt J; Schwinge D; Schoknecht T; Quaas A; Sobottka I; Burandt E; Becker C; Neurath MF; Lohse AW; Herkel J; Schramm C
Hepatology; 2013 Sep; 58(3):1084-93. PubMed ID: 23564624
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis: a comparison study with dual-energy X-ray absorptiometry.
Keller S; Ittrich H; Schramm C; Lohse AW; Amling M; Adam G; Yamamura J
Jpn J Radiol; 2016 Oct; 34(10):677-683. PubMed ID: 27492220
[TBL] [Abstract][Full Text] [Related]
6. Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC).
Kunzmann LK; Schoknecht T; Poch T; Henze L; Stein S; Kriz M; Grewe I; Preti M; Hartl J; Pannicke N; Peiseler M; Sebode M; Zenouzi R; Horvatits T; Böttcher M; Petersen BS; Weiler-Normann C; Hess LU; Ahrenstorf AE; Lunemann S; Martrus G; Fischer L; Li J; Carambia A; Kluwe J; Huber S; Lohse AW; Franke A; Herkel J; Schramm C; Schwinge D
Hepatology; 2020 Oct; 72(4):1310-1326. PubMed ID: 33090557
[TBL] [Abstract][Full Text] [Related]
7. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
8. Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC).
Thoeni C; Perciani CT; Nakib D; Camat D; McGilvray ID; MacParland SA; Fischer S
Histopathology; 2023 Oct; 83(4):559-568. PubMed ID: 37488782
[TBL] [Abstract][Full Text] [Related]
9. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients.
Stürznickel J; Behler-Janbeck F; Baranowsky A; Schmidt T; Schwinge D; John C; Lohse AW; Schramm C; Heeren J; Schinke T; Amling M
Sci Rep; 2022 Oct; 12(1):16491. PubMed ID: 36192408
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
12. Protective potential of the gallbladder in primary sclerosing cholangitis.
Cazzagon N; Gonzalez-Sanchez E; El-Mourabit H; Wendum D; Rainteau D; Humbert L; Corpechot C; Chazouillères O; Arrivé L; Housset C; Lemoinne S
JHEP Rep; 2023 Apr; 5(4):100649. PubMed ID: 36923239
[TBL] [Abstract][Full Text] [Related]
13. Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis.
Campbell MS; Lichtenstein GR; Rhim AD; Pazianas M; Faust T
Liver Int; 2005 Apr; 25(2):311-6. PubMed ID: 15780055
[TBL] [Abstract][Full Text] [Related]
14. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
15. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
[TBL] [Abstract][Full Text] [Related]
16. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
[TBL] [Abstract][Full Text] [Related]
18. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.
Angulo P; Therneau TM; Jorgensen A; DeSotel CK; Egan KS; Dickson ER; Hay JE; Lindor KD
J Hepatol; 1998 Nov; 29(5):729-35. PubMed ID: 9833910
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.
Mende S; Schulte S; Strack I; Hunt H; Odenthal M; Pryymachuck G; Quasdorff M; Demir M; Nierhoff D; Dienes HP; Goeser T; Steffen HM; Töx U
Dig Dis Sci; 2013 May; 58(5):1271-81. PubMed ID: 23247798
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis.
Müller AL; Casar C; Preti M; Krzikalla D; Gottwick C; Averhoff P; Rosenstiel P; Gelderblom M; Altfeld M; Lohse AW; Steinmann S; Sebode M; Krause J; Schwinge D; Schramm C; Carambia A; Herkel J
J Hepatol; 2022 Dec; 77(6):1532-1544. PubMed ID: 35798133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
